Članki

Samo Kuzmič, Martina Hrast, Rok Frlan
The synthesis of (2R)-aziridine-2-carboxylic acid containing dipeptides
Acta chimica slovenica, 2022, Vol. 69, no. 2, 9, str. 261-270
https://journals.matheo.si/index.php/ACSi/article/view/6673

Arunima Murgai ... [et al.]
Targeting the deubiquitinase USP7 for degradation with PROTACs
Chemical communications, 2022, Vol. 58, iss. 61, str. 8858-8861
https://pubs.rsc.org/en/content/articlelanding/2022/cc/d2cc02094g

Péter Ábrányi-Balogh ... [et al.]
Next-generation heterocyclic electrophiles as small-molecule covalent MurA inhibitors
Pharmaceuticals, 2022, Vol. 15, iss. 12, art. 1484, 2022, 10 str.
https://www.mdpi.com/1424-8247/15/12/1484

Samo Guzelj ... [et al.]
Lipidation of NOD2 agonists with adamantane and stearoyl moieties differentially regulates their In vivo adjuvant activity
Pharmaceutics, 2022, Vol. 14, iss. 12, art. 2755, 9 str.
https://www.mdpi.com/1999-4923/14/12/2755

Nanca Cebron Lipovec, Andrej Anderlic, and Igor Locatelli
General antidepressants prescribing trends 2009–2018 in Slovenia: a cross-sectional retrospective database study
International journal of psychiatry in clinical practice, 2022, Vol. 26, iss. 4, str. 401-405
https://www.tandfonline.com/doi/full/10.1080/13651501.2022.2057331

Samo Guzelj, Špela Bizjak, and Žiga Jakopin
Discovery of desmuramylpeptide NOD2 agonists with single-digit nanomolar potency
ACS Medicinal Chemistry Letters, 2022, Vol. 13, iss. 8, 2022, str. 1270-1277
https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.2c00121

Anže Meden ... [et al.]
Pseudo-irreversible butyrylcholinesterase inhibitors: SAR, kinetic, computational, and crystallographic study of the N-dialkyl O-arylcarbamate warhead
ChemRxiv, 2022, str. 1-56
https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/62f0fc5069f3a57e38afcb23/original/pseudo-irreversible-butyrylcholinesterase-inhibitors-sar-kinetic-computational-and-crystallographic-study-of-the-n-dialkyl-o-arylcarbamate-warhead.pdf

Samo Guzelj ... [et al.]
Covalently conjugated NOD2/TLR7 agonists are potent and versatile immune potentiators
Journal of medicinal chemistry, 2022, Vol. 65, no. 22, str. 15085–15101
https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.2c00808#

Živa Zajec ... [et al.]
Optimisation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as novel Hsp90 C-terminal domain inhibitors against Ewing sarcoma
Bioorganic chemistry, 2022, Vol. 131, 2022, str. 1-16
https://www.sciencedirect.com/science/article/pii/S0045206822007179

Matic Proj ... [et al.]
Fragment-sized thiazoles in fragment-based drug discovery campaigns: friend or foe
ACS Medicinal Chemistry Letters, 2022, Vol. 13, iss. 12, str. 1905–1910
https://pubs.acs.org/doi/10.1021/acsmedchemlett.2c00429